Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Proc Natl Acad Sci U S A ; 107(42): 17933-8, 2010 Oct 19.
Article in English | MEDLINE | ID: mdl-20921366

ABSTRACT

Nature frequently utilizes opposing factors to create a stable activator gradient to robustly control pattern formation. This study employs a biomimicry approach, by delivery of both angiogenic and antiangiogenic factors from spatially restricted zones of a synthetic polymer to achieve temporally stable and spatially restricted angiogenic zones in vivo. The simultaneous release of the two spatially separated agents leads to a spatially sharp angiogenic region that is sustained over 3 wk. Further, the contradictory action of the two agents leads to a stable level of proangiogenic stimulation in this region, in spite of significant variations in the individual release rates over time. The resulting spatially restrictive and temporally sustained profiles of active signaling allow the creation of a spatially heterogeneous and functional vasculature.


Subject(s)
Angiogenesis Inhibitors/administration & dosage , Vascular Endothelial Growth Factor A/administration & dosage , Animals , Cells, Cultured , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Humans , Mice , Mice, SCID
2.
FASEB J ; 21(14): 3896-903, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17644610

ABSTRACT

Growth factors have been widely used in strategies to regenerate and repair diseased tissues, but current therapies that go directly from bench to bedside have had limited clinical success. We hypothesize that engineering successful therapies with recombinant proteins will often require specific quantitative information of the spatiotemporal role of the factors and the development of sophisticated delivery approaches that provide appropriate tissue exposures. This hypothesis was tested in the context of therapeutic angiogenesis. An in vitro model of angiogenesis was adapted to quantify the role of the concentration/gradient of vascular endothelial growth factor [VEGF(165)] on microvascular endothelial cells, and a delivery system was then designed, based on a mathematical model, to provide the desired profile in ischemic mice hindlimbs. This system significantly enhanced blood vessel formation, and perfusion and recovery from severe ischemia. This general approach may be broadly applicable to growth factor therapies.


Subject(s)
Drug Delivery Systems/methods , Vascular Endothelial Growth Factor A/administration & dosage , Animals , Cells, Cultured , Disease Models, Animal , Hindlimb/blood supply , Humans , Ischemia/drug therapy , Ischemia/metabolism , Mice , Mice, SCID , Neovascularization, Physiologic/drug effects , Vascular Endothelial Growth Factor A/therapeutic use
3.
Integr Biol (Camb) ; 4(3): 292-300, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22318325

ABSTRACT

Many biological processes, including angiogenesis, involve intercellular feedback and temporal coordination, but inference of these relations is often drowned in low sample sizes or noisy population data. To address this issue, a methodology was developed to statistically study spatial lateral inhibition and temporal synchronization in one specific biological process, endothelial sprouting mediated by Notch signaling. Notch plays an essential role in the development of organized vasculature, but the effects of Notch on the temporal characteristics of angiogenesis are not well understood. Results from this study showed that Notch lateral inhibition operates at distances less than 31 µm. Furthermore, combining time lapse microscopy with an intraclass correlation model typically used to analyze family data showed intrinsic temporal synchronization among endothelial sprouts originating from the same microcarrier. Such synchronization was reduced with Notch inhibitors, but was enhanced with the addition of Notch ligands. These results indicate that Notch plays a critical role in the temporal regulation of angiogenesis, as well as spatial control, and this method of analysis will be of significant utility in studies of a variety of other biological processes.


Subject(s)
Endothelial Cells/cytology , Endothelial Cells/physiology , Neovascularization, Physiologic , Human Umbilical Vein Endothelial Cells , Humans , Ligands , Models, Biological , Models, Statistical , Neovascularization, Physiologic/drug effects , Receptors, Notch/antagonists & inhibitors , Receptors, Notch/physiology , Signal Transduction , Systems Biology
4.
Pharm Res ; 24(2): 258-64, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17191092

ABSTRACT

PURPOSE: Biological mechanisms of tissue regeneration are often complex, involving the tightly coordinated spatial and temporal presentation of multiple factors. We investigated whether spatially compartmentalized and sequential delivery of factors can be used to pattern new blood vessel formation. MATERIALS AND METHODS: A porous bi-layered poly(lactide-co-glycolide) (PLG) scaffold system was used to locally present vascular endothelial growth factor (VEGF) alone in one spatial region, and sequentially deliver VEGF and platelet-derived growth factor (PDGF) in an adjacent region. Scaffolds were implanted in severely ischemic hindlimbs of SCID mice for 2 and 6 weeks, and new vessel formation was quantified within the scaffolds. RESULTS: In the compartment delivering a high dose of VEGF alone, a high density of small, immature blood vessels was observed at 2 weeks. Sequential delivery of VEGF and PDGF led to a slightly lower blood vessel density, but vessel size and maturity were significantly enhanced. Results were similar at 6 weeks, with continued remodeling of vessels in the VEGF and PDGF layer towards increased size and maturation. CONCLUSIONS: Spatially localizing and temporally controlling growth factor presentation for angiogenesis can create spatially organized tissues.


Subject(s)
Blood Vessels/growth & development , Neovascularization, Physiologic/drug effects , Platelet-Derived Growth Factor/administration & dosage , Platelet-Derived Growth Factor/pharmacology , Vascular Endothelial Growth Factor A/administration & dosage , Vascular Endothelial Growth Factor A/pharmacology , Animals , Blood Vessels/drug effects , Drug Delivery Systems , Hindlimb/blood supply , Immunohistochemistry , Ischemia/pathology , Mice , Models, Statistical , Platelet-Derived Growth Factor/metabolism , Regional Blood Flow/drug effects , Vascular Endothelial Growth Factor A/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL